Evaluating the population-level effects of overdose prevention sites and supervised consumption sites in British Columbia, Canada: controlled interrupted time series.

BACKGROUND: On 14 April 2016, British Columbia's Provincial Medical Health Officer declared the overdose crisis a public health emergency, sanctioning the implementation of new overdose prevention sites (OPS) and supervised consumption sites (SCS) across the province. METHODS: We used the BC Centre for Disease Control's Provincial Overdose Cohort of all overdose events between 1 January 2015 and 31 December 2017 to evaluate the population-level effects of OPSs and SCSs on acute health service use and mortality. We matched local health areas (LHA) that implemented any site with propensity score matched controls and conducted controlled interrupted time series analysis. RESULTS: During the study period, twenty-five OPSs and SCSs opened across fourteen of British Columbia's 89 LHAs. Results from analysis of LHAs with matched controls (i.e. excluding Vancouver DTES) were mixed. Significant declines in reported overdose events, paramedic attendance, and emergency department visits were observed. However, there were no changes to trends in monthly hospitalization or mortality rates. Extensive sensitivity analyses found these results persisted. CONCLUSIONS: We found OPSs and SCSs reduce opioid-related paramedic attendance and emergency department visit rates but no evidence that they reduce local hospitalization or mortality rates

How access, appropriateness, and quality of care affect patient outcomes for time-sensitive medical emergencies in British Columbia, Canada

ABSTRACT Objectives Cox Proportional Hazards models tested the relationship between access to care for time sensitive medical events and 30-day survival while controlling for appropriateness and quality of care. Approach A population study of all acute myocardial infarction (AMI), trauma, and stroke events treated within British Columbia between April 1st 1999 and March 31st 2013. Data sources included: the Discharge Abstract Database (DAD); a registry file; the Vital Statistics Mortality data; and the Medical Services Plan (MSP) Payment Information. Access to care was estimated with a de-identified residential postal code to hospital distance matrix developed using origin-destination network analysis in ArcGIS 10.2. Appropriateness of care compared national protocols with treatment received. Care that was contraindicated, outdated, or at an inexperienced facility was inappropriate. Quality of care was an outcome measure that used risk-standardized mortality ratios and funnel plots to identify hospitals that offered poor care. Results There were 106,409 AMI, 220,602 trauma, and 88,136 stroke events that occurred during the study period and used in condition specific hierarchical hazards models. Adjusted hazards ratios (aHR) found access to care were not associated with 30-day mortality after controlling for appropriateness and quality of care along with patient (i.e. age, sex, income, rurality, frailty) and system specific (i.e. method of transport, transfer patterns, facility volume, rurality, peer group) characteristics. Appropriate care reduced the hazard of mortality for all three conditions: AMI aHR=0.860 (95% CI=0.792-0.993, p-value=0.0003); stroke aHR=0.448 (95% CI=0.324-0.619, p-value<0.0001) and trauma aHR=0.824 (95% CI=0.703-0.967, p-value=0.0176). Quality of care reduced hazards of mortality for trauma (aHR=0.689, 95% CI=0.586-0.808, p-value<0.0001) and stroke (aHR=0.762, 95% CI=0.689-0.842, p-value<0.0001). Inter-hospital transfers were protective for AMI (aHR=0.513, 95% CI=0.406-0.649, p-value<0.0001) and stroke (aHR=0.768, 95% CI=0.630-0.936, p-value=0.0089) but detrimental for trauma (aHR=1.583, 95%CI=1.310-1.913, p-value<0.0001). Method of transport was also significant. Self-transport was protective for trauma (aHR=0.462, 95% CI=0.417-0.513, p-value<0.0001) and stroke (aHR=0.330, 95% CI=0.301-0.363, p-value<0.0001). Older age was associated with higher mortality rates across all three conditions (p-value<0.0001) and being female increased the hazard of death for AMI (aHR=1.049, 95% CI=1.010-1.088, p-value=0.0125) but was protective for trauma (aHR=0.583, 95% CI=0.551-0.617, p-value<0.0001) events. Conclusion As health systems evolve to meet the needs of their patients and work to provide equitable care under economic pressure for efficiency, it is important to understand how access, appropriateness and quality of care affect patient outcomes and distribute services accordingly

The effects of British Columbia hospital closures on delivery of health care services and the population's health

Background: In 2002, British Columbia (BC) began redistributing its hospital services. Existing facilities closed, were downsized or became specialized. Reasons for these changes included the centralization of the health authorities and subsequently the redistribution of services, along with safety concerns regarding small units, difficulties recruiting and retaining staff, and policy changes in the province’s Standards of Accessibility. At the same time, innovations in service delivery, such as inter-hospital transfer practices and telehealth initiatives (e.g. telestroke), modified how health care is provided. Effective health service delivery is a complex matter. Over a decade since redistribution began, there has been no evaluation of the changes in service distribution and their impact on patient health. Methods: This is a retrospective cohort study of all adult (18 years and over) acute myocardial infarction (AMI), stroke, and severe trauma events that occurred within the province between April 1 1999 and March 31 2013. Using administrative data, segmented regression and hierarchical hazards modelling techniques, this study examines the effect of service redistribution on patients’ mortality outcomes. Results: The interrupted time series models found service redistribution was not associated with changes in 30-day mortality outcomes, and was likely a response to facility underutilization. Although there was extensive variation in patient access to care (travel burden) across health authorities, the hierarchical Cox proportional hazards models showed that long travel time (>30 mins) was not associated with patient short term mortality after controlling for appropriateness and quality of care along with compensating mechanisms such as inter-hospital transfers, and telehealth services. Conclusion: This work demonstrates that efficiencies in health system delivery can be gained by eliminating underutilized acute care services but also identifies challenges in ensuring equitable access to care.Medicine, Faculty ofGraduat

Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada

Background: Regional variation in medical care costs can indicate heterogeneity in clinical practice, inequities in access, or inefficiencies in service delivery. We aimed to estimate regional variation in medical costs for people living with HIV (PLHIV), adjusting for demographics and case-mix. Methods: We conducted a retrospective cohort study using linked health administrative databases of PLHIV, from 2010 to 2014, in British Columbia (BC), Canada. Quarterly health care costs (2018 CAD) were derived from inpatient, outpatient, prescription drugs, antiretroviral therapy (ART), and HIV diagnostics. We used a two-part model with a logit link for the probability of incurring costs, and a log link and gamma distribution for observations with positive costs. We also estimated quarterly utilization rates for hospitalization-, physician billing- and prescription drug-days. Primary variables were indicators of individuals’ Health Service Delivery Area (HSDA). We adjusted cost and utilization estimates for demographic characteristics, HIV-disease progression, and comorbidities. Results: Our cohort included 9577 PLHIV (median age 45.5 years, 80% male). Adjusted total quarterly costs for all 16 HSDAs were within 20% of the provincial mean, 8/16 for hospitalization costs, 16/16 for physician billing costs and 10/16 for prescription drug costs. Northern Interior and Northeast HSDAs had 38 and 44% lower quarterly non-ART prescription drug costs, and 2 and 5% higher quarterly inpatient costs, respectively. Conclusions: We observed limited variation in medical care costs and utilization among PLHIV in BC. However, lower levels of outpatient care and higher levels of inpatient care indicate possible barriers to accessing care among PLHIV in the most rural regions of the province.Medicine, Faculty ofOther UBCNon UBCMedicine, Department ofReviewedFacult

Identifying mental health and substance use disorders using emergency department and hospital records: a population-based retrospective cohort study of diagnostic concordance and disease attribution.

OBJECTIVES: Administrative data are increasingly being used for surveillance and monitoring of mental health and substance use disorders (MHSUD) across Canada. However, the validity of the diagnostic codes specific to MHSUD is unknown in emergency departments (EDs). Our objective was to determine the concordance, and individual-level and hospital-level factors associated with concordance, between diagnosis codes assigned in ED and at discharge from hospital for MHSUD-related conditions. DESIGN: Population-based retrospective cohort study. SETTING: EDs and hospitals within Vancouver Coastal Health Authority (VCH), British Columbia, Canada. PARTICIPANTS: 16 926 individuals who were admitted into a VCH hospital following an ED visit from 1 April 2009 to 31 March 2017, contributing to 48 116 pairs of ED and hospital discharge diagnoses. PRIMARY AND SECONDARY OUTCOME MEASURES: We examined concordance in identifying MHSUD between the primary discharge diagnosis codes based on the International Statistical Classification of Diseases, 9th and 10th Revisions (Canada) assigned in the ED and those assigned in the hospital among all ED visits resulting in a hospital admission. We calculated the percent overall agreement, positive agreement, negative agreement and Cohen's kappa coefficient. We performed multiple regression analyses to identify factors independently associated with discordance. RESULTS: We found a high level of concordance for broad categories of MH conditions (overall agreement=0.89, positive agreement=0.74 and kappa=0.67), and a fair level of concordance for SUDs (overall agreement=0.89, positive agreement=0.31 and kappa=0.27). SUDs were less likely to be indicated as the primary cause in ED as opposed to in hospital (3.8% vs 11.7%). In multiple regression analyses, ED visits occurring during holidays, weekends and overnight (21:00-8:59 hours) were associated with increased odds of discordance in identifying MH conditions (adjusted OR 1.47, 95% CI 1.11 to 1.93; 1.27, 95% CI 1.16 to 1.40; 1.30, 95% CI 1.19 to 1.42, respectively). CONCLUSIONS: ED data could be used to improve surveillance and monitoring of MHSUD. Future efforts are needed to improve screening for individuals with MHSUD and subsequently connect them to treatment and follow-up care

Evaluating Montreál's harm reduction interventions for people who inject drugs: protocol for observational study and cost-effectiveness analysis

Introduction The main harm reduction interventions for people who inject drugs (PWID) are supervised injection facilities, needle and syringe programmes and opioid agonist treatment. Current evidence supporting their implementation and operation underestimates their usefulness by excluding skin, soft tissue and vascular infections (SSTVIs) and anoxic/toxicity-related brain injury from cost-effectiveness analyses (CEA). Our goal is to conduct a comprehensive CEA of harm reduction interventions in a setting with a large, dispersed, heterogeneous population of PWID, and include prevention of SSTVIs and anoxic/toxicity-related brain injury as measures of benefit in addition to HIV, hepatitis C and overdose morbidity and mortalities averted. Methods and analysis This protocol describes how we will develop an open, retrospective cohort of adult PWID living in Québec between 1 January 2009 and 31 December 2020 using administrative health record data. By complementing this data with non-linkable paramedic dispatch records, regional monthly needle and syringe dispensation counts and repeated cross-sectional biobehavioural surveys, we will estimate the hazards of occurrence and the impact of Montreál's harm reduction interventions on the incidence of drug-use-related injuries, infections and deaths. We will synthesise results from our empirical analyses with published evidence to simulate infections and injuries in a hypothetical population of PWID in Montreál under different intervention scenarios including current levels of use and scale-up, and assess the cost-effectiveness of each intervention from the public healthcare payer's perspective. Ethics and dissemination This study was approved by McGill University's Institutional Review Board (Study Number: A08-E53-19B). We will work with community partners to disseminate results to the public and scientific community via scientific conferences, a publicly accessible report, op-ed articles and open access peer-reviewed journals

Inability to access health and social services associated with mental health among people who inject drugs in a Canadian setting

Background: People who inject drugs (PWID) face barriers to healthcare due to reasons including comorbidity. We evaluated access to health and social services by three of the most prevalent comorbid conditions among PWID: HIV, hepatitis C (HCV), and mental health, in an urban setting in Canada. Methods: Data were derived from prospective cohorts of community-recruited PWID between 2005 and 2015. HIV and HCV serostatuses were based on antibody tests, while mental health conditions and inability to access health and social services (barriers to access) were determined by participants’ self-report. We employed generalized linear mixed models controlling for confounders to examine associations between health conditions and barriers to access. Results: Among 2494 participants, 1632 (65.4%) reported barriers to access at least once over a median of seven (IQR: 3, 12) semi-annual assessments. Mental health conditions were independently associated with increased odds of reporting barriers (adjusted Odds Ratio (aOR): 1.45, 95% Confidence Interval (CI): 1.32, 1.58), while HIV was not (aOR: 0.96, 95% CI: 0.85, 1.08), and HCV was associated with decreased odds (aOR: 0.80, 95% CI: 0.69, 0.93). The associations between mental health conditions and barriers to access were consistent among PWID without HIV/HCV (aOR: 1.35, 95% CI: 1.10, 1.65), with HCV mono-infection (aOR: 1.55, 95% CI: 1.37, 1.75), and HCV/HIV co-infection (aOR: 1.36, 95% CI: 1.15, 1.60). Conclusions: Targeted strategies to seek and treat mental health conditions in settings that serve PWID, and assist PWID with mental health conditions in navigating healthcare system may improve the publicly-funded health and social services.Medicine, Faculty ofOther UBCNon UBCMedicine, Department ofPopulation and Public Health (SPPH), School ofReviewedFacultyResearcherPostdoctora

Temporal Trends and Determinants of HIV Testing at Antenatal Care in Sub-Saharan Africa: A Pooled Analysis of Population-Based Surveys (2005-2021).

In sub-Saharan Africa (SSA), integrating HIV testing into antenatal care (ANC) has been crucial toward reducing mother-to-child transmission of HIV. With the introduction of new testing modalities, we explored temporal trends in HIV testing within and outside of ANC and identified sociodemographic determinants of testing during ANC.SCOPUS: ar.jinfo:eu-repo/semantics/publishe

Characteristics of male perpetrators of intimate partner violence and implications for women's HIV status: A pooled analysis of cohabiting couples from 27 countries in Africa (2000-2020).

Intimate partner violence (IPV) may increase women's HIV acquisition risk. Still, knowledge on pathways through which IPV exacerbates HIV burden is emerging. We examined the individual and partnership-level characteristics of male perpetrators of physical and/or sexual IPV and considered their implications for women's HIV status. We pooled individual-level data from nationally representative, cross-sectional surveys in 27 countries in Africa (2000-2020) with information on past-year physical and/or sexual IPV and HIV serology among cohabiting couples (≥15 years). Current partners of women experiencing past-year IPV were assumed to be IPV perpetrators. We used Poisson regression, based on Generalized Estimating Equations, to estimate prevalence ratios (PR) for male partner and partnership-level factors associated with perpetration of IPV, and men's HIV status. We used marginal standardization to estimate the adjusted risk differences (aRD) quantifying the incremental effect of IPV on women's risk of living with HIV, beyond the risk from their partners' HIV status. Models were adjusted for survey fixed effects and potential confounders. In the 48 surveys available from 27 countries (N = 111,659 couples), one-fifth of women reported that their partner had perpetrated IPV in the past year. Men who perpetrated IPV were more likely to be living with HIV (aPR = 1.09; 95%CI: 1.01-1.16). The aRD for living with HIV among women aged 15-24 whose partners were HIV seropositive and perpetrated past-year IPV was 30% (95%CI: 26%-35%), compared to women whose partners were HIV seronegative and did not perpetrate IPV. Compared to the same group, aRD among women whose partner was HIV seropositive without perpetrating IPV was 27% (95%CI: 23%-30%). Men who perpetrated IPV are more likely to be living with HIV. IPV is associated with a slight increase in young women's risk of living with HIV beyond the risk of having an HIV seropositive partner, which suggests the mutually reinforcing effects of HIV/IPV